Literature DB >> 11287599

Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.

M S Orandle1, K C Williams, A G MacLean, S V Westmoreland, A A Lackner.   

Abstract

The influence of host cytokine response on viral load, disease progression, and neurologic lesions was investigated in the simian immunodeficiency virus (SIV)-infected macaque model of AIDS. Cytokine gene expression (interleukin-1beta [IL-1beta], IL-2, IL-6, IL-10, gamma interferon [IFN-gamma], and tumor necrosis factor alpha [TNF-alpha]) and viral loads were evaluated by semiquantitative reverse transcription-PCR in lymph nodes of 5 control animals and 28 animals infected with SIVmac251 at the terminal stages of AIDS. Infected animals showed higher expression of IFN-gamma, IL-6, and IL-10 mRNAs compared with controls. Levels of all cytokines were comparable between animals with rapid (survival, <200 days) or slow/normal (survival, >200 days) disease progression. However, among rapid progressors, the eight animals with SIV encephalitis had a unique cytokine profile (increased IL-2, IL-6, and IFN-gamma) that was associated with higher viral loads. These observations provide evidence that host cytokine responses may influence SIV neuropathogenesis independent of disease progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287599      PMCID: PMC114195          DOI: 10.1128/JVI.75.9.4448-4452.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Cytokine patterns and viral load in lymph nodes during the early stages of SIV infection.

Authors:  E Khatissian; L Chakrabarti; B Hurtrel
Journal:  Res Virol       Date:  1996 Mar-Jun

2.  Cytokine mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection of macaques.

Authors:  A Chéret; R Le Grand; P Caufour; N Dereuddre-Bosquet; F Matheux; O Neildez; F Théodoro; N Maestrali; O Benveniste; B Vaslin; D Dormont
Journal:  AIDS Res Hum Retroviruses       Date:  1996-09-01       Impact factor: 2.205

3.  Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro.

Authors:  M Bayard-McNeeley; H Doo; S He; A Hafner; W D Johnson; J L Ho
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

4.  Localization of simian immunodeficiency virus nucleic acid and antigen in brains of fetal macaques inoculated in utero.

Authors:  J H Lane; A F Tarantal; D Pauley; M Marthas; C J Miller; A A Lackner
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

5.  Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children.

Authors:  S Than; R Hu; N Oyaizu; J Romano; X Wang; S Sheikh; S Pahwa
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

6.  CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection.

Authors:  S Zanussi; C Simonelli; M D'Andrea; C Caffau; M Clerici; U Tirelli; P DePaoli
Journal:  Clin Exp Immunol       Date:  1996-08       Impact factor: 4.330

7.  A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3.

Authors:  V Hirsch; D Adger-Johnson; B Campbell; S Goldstein; C Brown; W R Elkins; D C Montefiori
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation.

Authors:  J H Lane; V G Sasseville; M O Smith; P Vogel; D R Pauley; M P Heyes; A A Lackner
Journal:  J Neurovirol       Date:  1996-12       Impact factor: 2.643

9.  Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection.

Authors:  M Clerici; C Balotta; L Meroni; E Ferrario; C Riva; D Trabattoni; A Ridolfo; M Villa; G M Shearer; M Moroni; M Galli
Journal:  AIDS Res Hum Retroviruses       Date:  1996-07-20       Impact factor: 2.205

10.  Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.

Authors:  H Schmidtmayerova; H S Nottet; G Nuovo; T Raabe; C R Flanagan; L Dubrovsky; H E Gendelman; A Cerami; M Bukrinsky; B Sherry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

View more
  33 in total

1.  Characterization of an in vitro rhesus macaque blood-brain barrier.

Authors:  Andrew G MacLean; Marlene S Orandle; John MacKey; Kenneth C Williams; Xavier Alvarez; Andrew A Lackner
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

2.  MCP-3/CCL7 production by astrocytes: implications for SIV neuroinvasion and AIDS encephalitis.

Authors:  Nicole A Renner; Nathan S Ivey; Rachel K Redmann; Andrew A Lackner; Andrew G MacLean
Journal:  J Neurovirol       Date:  2011-01-29       Impact factor: 2.643

3.  Characterization of Cellular Immune Responses in Thai Individuals With and Without HIV-Associated Neurocognitive Disorders.

Authors:  Silvia Ratto-Kim; Alexandra Schuetz; Pasiri Sithinamsuwan; John Barber; Nicholas Hutchings; Sukalaya Lerdlum; James L K Fletcher; Yuwadee Phuang-Ngern; Weerawan Chuenarom; Somporn Tipsuk; Mantana Pothisri; Tanate Jadwattanakul; Supunnee Jirajariyavej; Chayada Sajjaweerawan; Siriwat Akapirat; Thep Chalermchai; Duanghathai Suttichom; Boot Kaewboon; Peeriya Prueksakaew; Putthachard Karnsomlap; David Clifford; Robert H Paul; Mark S de Souza; Jerome H Kim; Jintanat Ananworanich; Victor Valcour
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-12       Impact factor: 2.205

4.  Microglia activation by SIV-infected macrophages: alterations in morphology and cytokine secretion.

Authors:  Nicole A Renner; Hope A Sansing; Lisa A Morici; Fiona M Inglis; Andrew A Lackner; Andrew G MacLean
Journal:  J Neurovirol       Date:  2012-04-26       Impact factor: 2.643

5.  Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.

Authors:  Takeo Kuwata; Houman Dehghani; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Tatsuhiko Igarashi; Joseph Mattapallil; Mario Roederer; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Simian immunodeficiency virus infection alters chemokine networks in lung tissues of cynomolgus macaques: association with Pneumocystis carinii infection.

Authors:  Shulin Qin; Beth A Fallert Junecko; Anita M Trichel; Patrick M Tarwater; Michael A Murphey-Corb; Denise E Kirschner; Todd A Reinhart
Journal:  Am J Pathol       Date:  2010-07-29       Impact factor: 4.307

7.  Cell tropism of simian immunodeficiency virus in culture is not predictive of in vivo tropism or pathogenesis.

Authors:  Juan T Borda; Xavier Alvarez; Ivanela Kondova; Pyone Aye; Meredith A Simon; Ronald C Desrosiers; Andrew A Lackner
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.

Authors:  Tatsuhiko Igarashi; Yasuyuki Endo; Yoshiaki Nishimura; Charles Buckler; Reza Sadjadpour; Olivia K Donau; Marie-Jeanne Dumaurier; Ronald J Plishka; Alicia Buckler-White; Malcolm A Martin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome.

Authors:  Ousmane M Diop; Mickaël J-Y Ploquin; Lorenzo Mortara; Abdourahmane Faye; Béatrice Jacquelin; Désirée Kunkel; Pierre Lebon; Cécile Butor; Anne Hosmalin; Françoise Barré-Sinoussi; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

10.  Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses.

Authors:  Yoshiaki Nishimura; Tatsuhiko Igarashi; Olivia K Donau; Alicia Buckler-White; Charles Buckler; Bernard A P Lafont; Robert M Goeken; Simoy Goldstein; Vanessa M Hirsch; Malcolm A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.